JP2021526123A5 - - Google Patents

Info

Publication number
JP2021526123A5
JP2021526123A5 JP2020540731A JP2020540731A JP2021526123A5 JP 2021526123 A5 JP2021526123 A5 JP 2021526123A5 JP 2020540731 A JP2020540731 A JP 2020540731A JP 2020540731 A JP2020540731 A JP 2020540731A JP 2021526123 A5 JP2021526123 A5 JP 2021526123A5
Authority
JP
Japan
Prior art keywords
alkyl
heterocycloalkyl
cycloalkyl
heteroaryl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020540731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021526123A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2019/089025 external-priority patent/WO2019228403A1/en
Publication of JP2021526123A publication Critical patent/JP2021526123A/ja
Publication of JP2021526123A5 publication Critical patent/JP2021526123A5/ja
Pending legal-status Critical Current

Links

JP2020540731A 2018-05-29 2019-05-29 オートタキシン阻害剤とその使用 Pending JP2021526123A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862677459P 2018-05-29 2018-05-29
US62/677,459 2018-05-29
US201862731003P 2018-09-13 2018-09-13
US62/731,003 2018-09-13
PCT/CN2019/089025 WO2019228403A1 (en) 2018-05-29 2019-05-29 Autotaxin inhibitors and uses thereof

Publications (2)

Publication Number Publication Date
JP2021526123A JP2021526123A (ja) 2021-09-30
JP2021526123A5 true JP2021526123A5 (cg-RX-API-DMAC7.html) 2022-05-27

Family

ID=68697812

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020540731A Pending JP2021526123A (ja) 2018-05-29 2019-05-29 オートタキシン阻害剤とその使用

Country Status (6)

Country Link
US (2) US10711000B2 (cg-RX-API-DMAC7.html)
EP (1) EP3728257A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021526123A (cg-RX-API-DMAC7.html)
CN (1) CN111801328B (cg-RX-API-DMAC7.html)
CA (1) CA3089527A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019228403A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019220064A1 (en) * 2018-02-14 2020-10-01 Suzhou Sinovent Pharmaceuticals Co., Ltd. Heterocyclic compound, application thereof and pharmaceutical composition comprising same
WO2019228403A1 (en) 2018-05-29 2019-12-05 Fronthera U.S. Pharmaceuticals Llc Autotaxin inhibitors and uses thereof
CN111393459B (zh) * 2020-04-16 2022-07-22 南京安纳康生物科技有限公司 Shp2抑制剂及其用途
JP2023533294A (ja) * 2020-07-09 2023-08-02 スージョウ アーク バイオファーマシューティカル カンパニー リミテッド Atx阻害剤及びその製造方法並びに使用
CN113912600A (zh) * 2020-07-09 2022-01-11 苏州爱科百发生物医药技术有限公司 一种atx抑制剂及其制备方法和应用
WO2022026922A2 (en) * 2020-07-31 2022-02-03 Genentech, Inc. Methods for treating exacerbations of inflammatory respiratory diseases
CN114315825A (zh) * 2020-09-30 2022-04-12 江西济民可信集团有限公司 吡啶并咪唑衍生物及其制备方法和应用
WO2022074459A2 (en) * 2020-10-06 2022-04-14 Ildong Pharmaceutical Co., Ltd. Autotaxin inhibitor compounds
EP4242208A4 (en) * 2020-11-04 2025-01-15 Xizang Haisco Pharmaceutical Co., Ltd. DEUTERATED DERIVATIVE USED AS ATX INHIBITOR, AND ITS APPLICATION
CN112675308B (zh) * 2020-12-09 2023-05-05 中国人民解放军军事科学院军事医学研究院 抑制enpp2基因和/或蛋白表达的物质在制备治疗多发性骨髓瘤的药物中的应用
FI4274572T3 (fi) 2021-01-05 2026-03-27 Zydus Lifesciences Ltd Uusia autotaksiinin inhibiittoreita
TW202309022A (zh) 2021-04-13 2023-03-01 美商努法倫特公司 用於治療具egfr突變之癌症之胺基取代雜環
TW202342138A (zh) * 2022-03-31 2023-11-01 大陸商蘇州愛科百發生物醫藥技術有限公司 Atx抑制劑或其鹽的結晶形式及其制備方法與應用
WO2023211684A2 (en) * 2022-04-29 2023-11-02 Noetix Pharma Llc Prevention and treatment of post-operative cognitive dysfunction (pocd)
WO2023247670A1 (en) * 2022-06-24 2023-12-28 F. Hoffmann-La Roche Ag New heterocyclic-carbonyl-cyclic compounds as magl inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014139882A1 (en) * 2013-03-14 2014-09-18 Galapagos Nv Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders
CN105339370B (zh) * 2013-06-19 2017-09-15 加拉帕戈斯股份有限公司 用于治疗炎症性疾病的化合物和及其药物组合物
TW201908293A (zh) * 2017-07-12 2019-03-01 美商必治妥美雅史谷比公司 作為rock抑制劑之5員及雙環雜環醯胺
AU2019220064A1 (en) * 2018-02-14 2020-10-01 Suzhou Sinovent Pharmaceuticals Co., Ltd. Heterocyclic compound, application thereof and pharmaceutical composition comprising same
JP7274767B2 (ja) 2018-05-24 2023-05-17 ▲広▼州市恒▲諾▼康医▲薬▼科技有限公司 芳香族複素環式化合物及びその医薬組成物
WO2019228403A1 (en) 2018-05-29 2019-12-05 Fronthera U.S. Pharmaceuticals Llc Autotaxin inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
AU2017382405B2 (en) Compositions and methods for inhibiting arginase activity
JP2024545233A5 (cg-RX-API-DMAC7.html)
CN107417691B (zh) 高效的抗赘生剂和抗增生剂
JP2021534124A5 (cg-RX-API-DMAC7.html)
JP2014528433A5 (cg-RX-API-DMAC7.html)
US20080182845A1 (en) Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection
RU2014105624A (ru) Соединения индазола, способ их применения и фармацевтическая композиция
JP2006507265A5 (cg-RX-API-DMAC7.html)
JP2021527638A5 (cg-RX-API-DMAC7.html)
JP2008526999A5 (cg-RX-API-DMAC7.html)
JP2022141692A5 (cg-RX-API-DMAC7.html)
JP2013529196A5 (cg-RX-API-DMAC7.html)
JP2011530500A5 (cg-RX-API-DMAC7.html)
JP2005504042A5 (cg-RX-API-DMAC7.html)
AR041055A1 (es) Derivados de benzoimidazol utiles como agentes antiproliferativos, composicion farmaceautica en base al compuesto y un procedimiento de preparacion del compuesto
JP2021523200A5 (cg-RX-API-DMAC7.html)
AR046297A1 (es) Inhibidores de la dpp - iv metodos para prepararlos y composiciones farmaceuticas que los contienen como agente activo
RU2016118768A (ru) Композиции, пригодные для лечения расстройств, связанных с kit
AR039570A1 (es) Antagonistas de los receptores de trombina
JP2016506959A5 (cg-RX-API-DMAC7.html)
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
JP2011517453A5 (cg-RX-API-DMAC7.html)
JP2013500342A5 (cg-RX-API-DMAC7.html)
JP2011506566A5 (cg-RX-API-DMAC7.html)
RU2010129929A (ru) Производные 5-оксо-3-пирролидинкарбоксамида в качестве модуляторов р2х7